Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)

NCT04783935

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Liverpool Hospital Liverpool, Australia
  • John Hunter Hospital New Lambton, Australia
  • Klinikum Klagenfurt Klagenfurt, Austria
  • Paracelsus Medical University Salzburg Salzburg, Austria
View all 46 locations
View Trial Details
Completed

The Gilenya Pregnancy Registry

NCT01285479

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Cambridge, Massachusetts, United States
  • Novartis Investigative Site Grand Forks, North Dakota, United States
  • Novartis Investigative Site Bahía Blanca, Buenos Aires, Argentina
View all 61 locations
View Trial Details
Completed

Comparative Effectiveness Study Telerehab Versus Conventional

NCT03468868

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +6 more
Locations
  • The Tanner Center for Multiple Sclerosis Birmingham, Alabama, United States
  • University of Alabama Birmingham, Alabama, United States
  • University of Colorado Denver, Colorado, United States
  • University of Georgia Athens, Georgia, United States
View Trial Details
Completed

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00676715

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Phoenix Neurological Associates Ltd Phoenix, Arizona, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • East Bay Physicians Med Group;Sutter East Bay Med Foundation Berkeley, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 84 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT04660539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Miami Miami, Florida, United States
  • Columbus Research and Wellness Columbus, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View all 53 locations
View Trial Details

Related conditions